EHMT2 and pancreatic adenocarcinoma: An enhancement in LC3-II levels and autophagosome numbers in mutant TP53 pancreatic adenocarcinoma PANC-1 cells are observed in the presence of a combination of gossypol (39) and BRD4770, an inhibitor of histone methyltransferase EHMT2/G9a (euchromatic histone lysine methyltransferase 2).